You just read:

Lipocine Announces Outcome of FDA Advisory Committee Meeting for TLANDO™, Testosterone Replacement Therapy in Adult Males with Hypogonadism

News provided by

Lipocine Inc.

Jan 10, 2018, 16:40 ET